Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2001 | 2018 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1998 | 2011 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2018 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2019 | ||||||||
|
Fli-1 proto-oncogene, ETS transcription factor | 0.468 | 0.692 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2006 | 2016 | ||||||||
|
tumor protein p53 binding protein 1 | 0.520 | 0.731 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2018 | ||||||||
|
interleukin 22 | 0.393 | 0.885 | 1.9E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1997 | 2019 | |||||||||
|
inducible T cell costimulator | 0.502 | 0.731 | 3.1E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIIa | 0.432 | 0.962 | 3.7E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2018 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2013 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2013 | 2019 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2007 | 2018 | ||||||||
|
RNA binding region (RNP1, RRM) containing 3 | 0.608 | 0.731 | 2.0E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1993 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2000 | 2019 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2020 | ||||||||
|
integrin subunit alpha L | 0.511 | 0.885 | 4.3E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
RAB4A, member RAS oncogene family | 0.705 | 0.577 | 0.20 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2020 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2006 | 2018 |